Phase 3 Depression and Anxiety Trial, Not Yet Recruiting NCT07507214 Sponsor: University of Florida Condition: Depression and Anxiety
Back to Depression And Anxiety

Phase 3 Depression and Anxiety Trial, Not Yet Recruiting

NCT07507214
Not Yet Recruiting Phase 3

voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice

Who may and may not be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who may be able to join

  • People who identify as female athletes, whether recreational or professional
  • People aged 18 to 65 years old
  • People who have been diagnosed with a concussion (at least 72 hours ago) and whose Post-Concussion Symptom Scale (PCSS) score is above 7, or who have more than 4 concussion-related symptoms present
  • People whose depression screening score (using a questionnaire called the PHQ-9) is 10 or higher, indicating moderate to severe depression
  • People whose depression has not responded to treatment, meaning they have taken or are currently taking an antidepressant tablet for at least 6 weeks

Who may not be able to join

Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.

  • People who are pregnant or breastfeeding
  • People with a history of seizures or epilepsy
  • People who have any implanted medical devices, such as cochlear implants, brain stimulators, aneurysm clips, or stents
  • People currently being treated with certain medications that can affect hearing (such as aminoglycosides or cisplatin)
  • People with a history of bipolar disorder
  • People who have a pacemaker or implanted defibrillator
  • People with an allergy or other medical reason that makes the study drug d-cycloserine unsuitable for them
  • People with other medical reasons identified by the lead researcher that would make participation unsuitable (confirm with trial site)
  • People who are unable to give informed consent due to language difficulties or other barriers
  • People who are currently incarcerated
  • People whose biological sex is male

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 30 June 2026

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Not Yet Recruiting
Phase
Phase 3
Registry
ClinicalTrials.gov
Start date
1 June 2026
Est. completion
1 June 2028

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Patient Health Questionnaire 9 (PHQ-9) depression symptom inventory scores; Sport Mental Health Assessment Tool 1 (SMHAT-1) depression symptom inventory scores

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 30 June 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov